TY - JOUR
T1 - Overview of new immunosuppressive therapies
AU - Nevins, Thomas E.
N1 - Copyright:
Copyright 2007 Elsevier B.V., All rights reserved.
PY - 2000
Y1 - 2000
N2 - This review covers the new immunosuppressive drugs that have appeared in the past 5 years. It begins with the newest formulation (Neoral, Sandoz Pharmaceuticals, East Hanover, NJ, USA) of the clinically 'mature' drug cyclosporin A and then reviews the literature on tacrolimus, sirolimus, and mycophenolate mofetil. In each case, the emphasis is on the evolution of experience with the drug and on the questions that the drug poses for pediatricians considering the risk-benefit ratio of the drug in children. (C) 2000 Lippincott Williams and Wilkins, Inc.
AB - This review covers the new immunosuppressive drugs that have appeared in the past 5 years. It begins with the newest formulation (Neoral, Sandoz Pharmaceuticals, East Hanover, NJ, USA) of the clinically 'mature' drug cyclosporin A and then reviews the literature on tacrolimus, sirolimus, and mycophenolate mofetil. In each case, the emphasis is on the evolution of experience with the drug and on the questions that the drug poses for pediatricians considering the risk-benefit ratio of the drug in children. (C) 2000 Lippincott Williams and Wilkins, Inc.
UR - http://www.scopus.com/inward/record.url?scp=0034103317&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0034103317&partnerID=8YFLogxK
U2 - 10.1097/00008480-200004000-00011
DO - 10.1097/00008480-200004000-00011
M3 - Review article
C2 - 10763765
AN - SCOPUS:0034103317
SN - 1040-8703
VL - 12
SP - 146
EP - 150
JO - Current Opinion in Pediatrics
JF - Current Opinion in Pediatrics
IS - 2
ER -